(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DREAMIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

DREAMIR

ST13

US500000098127327

Class

42

Filing

98127327

Registration

7479144

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

14

Latest update

08/20/2024

Trademark type

Combined

Nice classes

42

Filing date

08/10/2023

Registration date

08/20/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/20/2024

Last transaction

08/20/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

07/01/2023

First use in commerce

07/01/2023

Drawing code

3

Owner type

03

Owner location

Gaithersburg, MD

Examiner

JOHNSON, KAREINE

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of an oval within which appears the word DREAMIR, with the "DREA" in uppercase font, the "mi" in lowercase font, and the "R" in uppercase font, along with images of a circle genomic sequencing , an antibody icon depiction and two human figures.

Holders and representatives

Holders

MIRECULE, INC.

Representatives

HAROLD KYLE KYLE & ASSOCIATES

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Research and development in the field of biotechnologyRNA-based therapeutics; providing a secured-accessmembers only website featuring a proprietary technology software platform containing sequencing profiles and clinical outcome data that gives users the ability to obtain information for research purposes related to creating RNA-based therapeutics

Publications

History of USPTO decisions and trademark events.

14 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

08/20/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

08/20/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/04/2024

PUBO

PUBLISHED FOR OPPOSITION

06/04/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/15/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/30/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

04/29/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/29/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

04/29/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/29/2024

DOCK

ASSIGNED TO EXAMINER

04/10/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/12/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/11/2023

NWAP

NEW APPLICATION ENTERED

08/14/2023

Continuous trademark protection

Get notified about every new filing that threatens DREAMIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.